Document is current
Any future updates will be listed below
-
Authors
Ziegler, Georg C. https://orcid.org/0000-0001-9411-3169
Groß, Silke
Boreatti, Andrea
Heine, Monika
McNeill, Rhiannon V. https://orcid.org/0000-0002-3297-9212
Kranz, Thorsten M. https://orcid.org/0000-0002-7233-9308
Romanos, Marcel https://orcid.org/0000-0001-7628-8299
Jacob, Christian P.
Reif, Andreas https://orcid.org/0000-0002-0992-634X
Kittel-Schneider, Sarah https://orcid.org/0000-0003-3057-6150
Lesch, Klaus-Peter https://orcid.org/0000-0001-8348-153X
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (413657723)
Deutsche Forschungsgemeinschaft (CRU 125)
Deutsche Forschungsgemeinschaft (CRU 125)
Deutsche Forschungsgemeinschaft (CRU 125)
Deutsche Forschungsgemeinschaft (CRU 125)
Horizon 2020 Framework Programme (728018)
- License Information
-
More Information
Article History
Received: 17 January 2024
Accepted: 9 October 2024
First Online: 5 November 2024
Declarations
:
: This study was conducted according to the latest guidelines of the Declaration of Helsinki. All procedures have been reviewed and approved by the Ethics Committee of the University of Würzburg under ethical approval number 141/03. All participants volunteered to take part in this study and gave written informed consent.
: CPJ received speaker's fees from derCampus, Daiichi Sankyo, Jansse-Cilag, Eli Lilly and Co, Shire, Novartis, and Medice. SKS received author's and speaker's honoraria from Takeda and Medice Arzneimittel Pütter GmbH & Co KG. AR has received honoraria from and/or serves on advisory boards for Medice, Shire/Takeda, SAGE/Biogen, Janssen, Boehringer Ingelheim, and cyclerion. All declared COI are not directly related to this work. None of the other authors reports any financial conflict of interest related to this work.
